Home Talphera

Talphera

In operation
Post-IPO Round
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Talphera, Inc. (formerly AcelRx Pharmaceuticals, Inc.) is a specialty pharmaceutical company dedicated to the development and commercialization of therapies for pain and other conditions. It offers NanoTab, an orally administered mucosal tablet. The company also provides the Sufentanil NanoTab PCA System, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for managing acute postoperative pain in hospital settings; the Sufentanil NanoTab BTP Management System for treatment options in cancer pain patients; and Sufentanil/Triazolam NanoTabs, which provide outpatient programs for analgesia and sedation. It serves patients, physicians, administrators, and payers.
Talphera, Inc.
California,United States of America
51~100 people
January 01, 2005
info@talphera.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Biological Drug Production
Concept
Disease Treatment # Pain
Application Scenarios
Innovative Drugs